HSD17B12 and neuroblastoma: We performed targeted lipidomic analysis in the silenced neuroblastoma cell lines SH‐SY5Y and SK‐N‐BE(2)C, both carrying the C/C risk genotype of rs2863002, to identify lipid metabolic alterations due to HSD17B12 silencing.